(19)
(11) EP 0 812 593 B8

(12) CORRECTED NEW EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B2)

(48) Corrigendum issued on:
10.11.2010 Bulletin 2010/45

(45) Date of publication and mentionof the opposition decision:
02.01.2008 Bulletin 2008/01

(45) Mention of the grant of the patent:
29.08.2001 Bulletin 2001/35

(21) Application number: 97101617.5

(22) Date of filing: 14.03.1994
(51) International Patent Classification (IPC): 
A61K 39/39(2006.01)

(54)

Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a

3-0-Deazylierte Monophosphoryl Lipid A enthaltende Impfstoff-Zusammensetzungen

Compositions vaccinales renfermant de lipide A monophosphorylique 3-0-desacétylé

(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT

(30) Priority: 23.03.1993 GB 9306029
23.02.1994 GB 9403417

(43) Date of publication of application:
17.12.1997 Bulletin 1997/51

(60) Divisional application:
01112703.2 / 1175912

(62) Application number of the earlier application in accordance with Art. 76 EPC:
94911894.7 / 0689454

(73) Proprietor: SmithKline Beecham Biologicals S.A.
1330 Rixensart (BE)

(72) Inventors:
  • Hauser, Pierre
    1330 Rixensart (BE)
  • Voet, Pierre
    1330 Rixensart (BE)
  • Slaoui, Moncef
    1330 Rixensart (BE)
  • Garcon-Johnson, Nathalie Marie-Josephe Claude
    1330 Rixensart (BE)
  • Desmons, Pierre
    1330 Rixensart (BE)

(74) Representative: Dalton, Marcus Jonathan William et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)


(56) References cited: : 
EP-A- 0 339 667
WO-A-92/11291
WO-A-92/16556
WO-A-94/19013
 WO-A-86/01826
WO-A-92/16231
WO-A-93/19780
   
  • INFECTION AND IMMUNITY, vol. 51, no. 3, March 1986, WASHINGTON D.C.,USA, pages 784-787, XP002039957 COURSAGET ET AL: "SIMULTANEOUS ADMINISTRATION OF DIPHTHERIA-TETANUS-PERTUSSIS-POLIO AND HEPATITIS B VACCINES IN A SIMPLIFIED IMMUNIZATION PROGRAM:IMMUNE RESPONSE TO DIPHTHERIA TOXOID,TETANUS TOXOID,PERTUSSIS,AND HEPATITIS B SURFACE ANTIGEN"